Dachaigh › Leukemia Lymphocytic Cronach › Tennessee › Nashville
Sgrùdaidhean clionaigeach Leukemia Lymphocytic Cronach ann an Nashville, TN
Tha 13 sgrùdaidhean airson Leukemia Lymphocytic Cronach a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A’ fastadhÌre 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A’ fastadhÌre 3
- Tennessee Oncology, Nashville
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A’ fastadhÌre 3
- Tennessee Oncology, Pllc Nashville, Nashville
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A’ fastadhÌre 3
- Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0031), Nashville
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A’ fastadhÌre 2
- SCRI Oncology Partners, Nashville
Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
A’ fastadhÌre 3
- SCRI Oncology Partners, Nashville
Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
A’ fastadhÌre 1/2
- SCRI Oncology Partners, Nashville
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
A’ fastadhÌre 3
- Sarah Cannon Research Institute SCRI, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A’ fastadhÌre 1/2
- TriStar BMT, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
A’ fastadhÌre 1
- Tennessee Oncology, Nashville
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A’ fastadhÌre 4
- Tennessee Oncology, Nashville
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A’ fastadhÌre 4
- Tennessee Oncology, Nashville
HPC Offered for PRESERVE Expansion
A’ fastadhSgrùdadh amharc
- Tristar Centennial Medical Center, Nashville
Sgrùdaidhean Leukemia Lymphocytic Cronach ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Columbus, OH28 sgrùdaidhean
- Durham, NC27 sgrùdaidhean
- Washington, DC22 sgrùdaidhean
- Seattle, WA20 sgrùdaidhean
- Rochester, MN18 sgrùdaidhean
- New York City, NY18 sgrùdaidhean
- Houston, TX17 sgrùdaidhean
- Baldwin Park, CA16 sgrùdaidhean
- Milwaukee, WI15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Cincinnati, OH14 sgrùdaidhean
Sgrùdaidhean eile ann an Nashville
- Aillse Sgamhain Neo-chealla-beag97 sgrùdaidhean
- Aillse a' bhroilleach81 sgrùdaidhean
- Ailse metastatach70 sgrùdaidhean
- Aillse colorectal69 sgrùdaidhean
- Aillse (gach seòrsa)65 sgrùdaidhean
- Cancer Ovarian49 sgrùdaidhean
- Aillse Prostata43 sgrùdaidhean
- Ailseachadh nan Sgamhan40 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil39 sgrùdaidhean
- Cancer Pancreatic39 sgrùdaidhean
- Ailse Endometrial38 sgrùdaidhean
- Melanoma33 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.